Sumitomo Mitsui Trust Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-97,513
Closed -$12.3M – 1096
2024
Q2
$12.3M Sell
97,513
-9,596
-9% -$1.5M 0.01% 690
2024
Q1
$19.7M Sell
107,109
-1,803
-2% -$343K 0.01% 711
2023
Q4
$19.6M Sell
108,912
-2,613
-2% -$407K 0.01% 709
2023
Q3
$17.7M Buy
111,525
+302
+0.3% +$49.4K 0.01% 723
2023
Q2
$15.7M Sell
111,223
-21,535
-16% -$3.45M 0.01% 742
2023
Q1
$22.4M Buy
132,758
+2,073
+2% +$370K 0.02% 708
2022
Q4
$22.1M Buy
+130,685
New +$23.7M 0.02% 697

Other funds holding RGEN

Sumitomo Mitsui Trust Group's RGEN Position: Q3 2024 in Review

Sumitomo Mitsui Trust Group sold out of Repligen (RGEN) in Q3 2024, closing a stake of 97,513 shares — an estimated $12.3M sold.

Sumitomo Mitsui Trust Group first reported a position in RGEN in Q4 2022 and held it in 7 quarters. The position peaked at $22.4M in Q1 2023. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • Sumitomo Mitsui Trust Group reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 97,513 Repligen shares in Q3 2024, an estimated $12.3M.
  • Sumitomo Mitsui Trust Group first reported a position in Repligen in Q4 2022 and held it in 7 quarters.
  • Sumitomo Mitsui Trust Group's Repligen position peaked at $22.4M in Q1 2023.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2024, filed 5 Nov 2024.